Metabolic collaboration between cells in the tumor microenvironment has a negligible effect on tumor growth
Journal article, 2024

The tumor microenvironment is composed of a complex mixture of different cell types interacting under conditions of nutrient deprivation, but the metabolism therein is not fully understood due to difficulties in measuring metabolic fluxes and exchange of metabolites between different cell types in vivo. Genome-scale metabolic modeling enables estimation of such exchange fluxes as well as an opportunity to gain insight into the metabolic behavior of individual cell types. Here, we estimated the availability of nutrients and oxygen within the tumor microenvironment using concentration measurements from blood together with a metabolite diffusion model. In addition, we developed an approach to efficiently apply enzyme usage constraints in a comprehensive metabolic model of human cells. The combined modeling reproduced severe hypoxic conditions and the Warburg effect, and we found that limitations in enzymatic capacity contribute to cancer cells’ preferential use of glutamine as a substrate to the citric acid cycle. Furthermore, we investigated the common hypothesis that some stromal cells are exploited by cancer cells to produce metabolites useful for the cancer cells. We identified over 200 potential metabolites that could support collaboration between cancer cells and cancer-associated fibroblasts, but when limiting to metabolites previously identified to participate in such collaboration, no growth advantage was observed. Our work highlights the importance of enzymatic capacity limitations for cell behaviors and exemplifies the utility of enzyme-constrained models for accurate prediction of metabolism in cells and tumor microenvironments.

Author

Johan Gustafsson

Chalmers, Biology and Biological Engineering

Fariba Roshanzamir

Chalmers, Life Sciences, Systems and Synthetic Biology

Anders Hagnestål

Hagnesia AB

Sagar M. Patel

University of Nebraska - Lincoln

Oseeyi I. Daudu

University of Nebraska - Lincoln

Donald F. Becker

University of Nebraska - Lincoln

Jonathan Robinson

BioInnovation Institute

Chalmers, Life Sciences, Systems and Synthetic Biology

Jens B Nielsen

Chalmers, Life Sciences, Systems and Synthetic Biology

BioInnovation Institute

Innovation

26666758 (eISSN)

Vol. 5 2 100583

Subject Categories

Cancer and Oncology

DOI

10.1016/j.xinn.2024.100583

PubMed

38445018

More information

Latest update

3/14/2024